The role of macrophages in rosacea: implications for targeted therapies.

immune system inflammation macrophage rosacea skin targeted therapies

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2023
Historique:
received: 25 04 2023
accepted: 14 07 2023
medline: 12 9 2023
pubmed: 11 9 2023
entrez: 11 9 2023
Statut: epublish

Résumé

Rosacea, a widespread chronic skin condition, may be influenced by macrophages, key immune cells in the skin, although their exact role is not yet fully understood. This review delves into the function of macrophages, their potential contribution to rosacea pathogenesis, current treatments, and promising macrophage-targeted therapies. It concludes by identifying knowledge gaps and potential areas for future rosacea research. Leveraging systematic and narrative literature review techniques, we conducted a comprehensive search of databases such as PubMed, Embase, and Web of Science. Utilizing keywords like "rosacea" and "macrophages", we targeted English articles from the last 5 years (2018-2023). We manually checked reference lists of relevant articles for additional studies. We included only articles emphasizing macrophages' role in rosacea and/or the development of related therapies and published within the specified timeframe. The systematic search of electronic databases yielded a total of 4,263 articles. After applying the inclusion and exclusion criteria, 156 articles were selected for inclusion in this review. These articles included original research studies, review articles, and clinical trials that focused on the role of macrophages in rosacea and/or the development of macrophage-targeted therapies for the disease. The selected articles provided a comprehensive and up-to-date overview of the current state of research on macrophages in rosacea, including their function in the skin, the potential mechanisms through which they may contribute to rosacea pathogenesis, and the current treatments and therapies available for the disease. Additionally, the articles identified gaps in knowledge regarding the role of macrophages in rosacea and suggested potential areas for future research. This literature review emphasizes the important role that macrophages, vital immune cells in the skin, may play in the pathogenesis of rosacea, a common chronic inflammatory skin disorder. The selected studies suggest potential mechanisms by which these cells might contribute to rosacea progression, although these mechanisms are not yet fully understood. The studies also spotlight current rosacea treatments and illuminate the promising potential of new macrophage-focused therapies. Despite these insights, significant gaps persist in our understanding of the precise role of macrophages in rosacea. Future research in this area could provide further insights into the pathogenesis of rosacea and contribute to the development of more effective, targeted therapeutic strategies.

Identifiants

pubmed: 37691916
doi: 10.3389/fimmu.2023.1211953
pmc: PMC10484341
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1211953

Informations de copyright

Copyright © 2023 Liu, Zhou, Chu and Jiang.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Clin Med. 2021 Mar 10;10(6):
pubmed: 33802085
Transplant Cell Ther. 2021 Oct;27(10):817-835
pubmed: 34217703
Clin Microbiol Rev. 2019 Jul 31;32(4):
pubmed: 31366611
Exp Dermatol. 2020 Jul;29(7):659-666
pubmed: 32434270
Br J Dermatol. 2019 Jul;181(1):65-79
pubmed: 30585305
Br J Dermatol. 2020 May;182(5):1269-1276
pubmed: 31392722
J Eur Acad Dermatol Venereol. 2022 Jul;36(7):987-1002
pubmed: 35278332
J Cosmet Dermatol. 2022 May;21(5):1895-1904
pubmed: 35104917
Dermatol Ther (Heidelb). 2020 Dec;10(6):1229-1253
pubmed: 33095403
J Clin Med. 2022 Dec 23;12(1):
pubmed: 36614915
Exp Dermatol. 2012 Dec;21(12):906-10
pubmed: 23171449
J Cosmet Dermatol. 2020 Sep;19(9):2182-2187
pubmed: 32621366
JCI Insight. 2019 Jan 10;4(1):
pubmed: 30626752
Acta Derm Venereol. 2019 Dec 1;99(13):1201-1209
pubmed: 31454051
Eur J Ophthalmol. 2021 Jan;31(1):22-33
pubmed: 32586107
Clin Rev Allergy Immunol. 2021 Feb;60(1):68-86
pubmed: 33236283
Immunol Res. 2018 Apr;66(2):271-280
pubmed: 29508205
J Immunol. 2021 Jul 15;207(2):555-568
pubmed: 34233910
J Eur Acad Dermatol Venereol. 2022 Aug;36 Suppl 8:3-11
pubmed: 35796500
Front Med (Lausanne). 2020 Jan 28;6:324
pubmed: 32047752
Med Res Rev. 2021 Nov;41(6):3023-3061
pubmed: 34288018
Medicine (Baltimore). 2023 Mar 3;102(9):e33023
pubmed: 36862896
Cells. 2021 Dec 16;10(12):
pubmed: 34944067
FEBS J. 2019 Aug;286(15):2830-2869
pubmed: 30908868
An Bras Dermatol. 2016 Sep-Oct;91(5):566-578
pubmed: 27828627
Cont Lens Anterior Eye. 2021 Jun;44(3):101326
pubmed: 32461053
Biochim Biophys Acta Mol Basis Dis. 2022 Dec 1;1868(12):166563
pubmed: 36174876
Ann Dermatol Venereol. 2022 Jun;149(2):99-107
pubmed: 34893359
J Leukoc Biol. 2020 Aug;108(2):485-491
pubmed: 32170886
Toxicol Appl Pharmacol. 2022 Sep 15;451:116189
pubmed: 35926563
Dermatol Clin. 2018 Apr;36(2):87-92
pubmed: 29499803
Parasite Immunol. 2019 Aug;41(8):e12658
pubmed: 31125450
Aust Prescr. 2018 Feb;41(1):20-24
pubmed: 29507456
Adv Ther. 2021 Mar;38(3):1415-1424
pubmed: 33507499
EMBO Mol Med. 2021 May 7;13(5):e13560
pubmed: 33734592
Arthritis Rheum. 2008 Aug;58(8):2432-42
pubmed: 18668591
Proc Natl Acad Sci U S A. 2020 Dec 1;117(48):30628-30638
pubmed: 33199625
Adv Drug Deliv Rev. 2022 Mar;182:114134
pubmed: 35122881
Methods Mol Biol. 2020;2059:1-54
pubmed: 31435914
J Autoimmun. 2022 Apr;128:102811
pubmed: 35278775
Biomedicines. 2022 Feb 16;10(2):
pubmed: 35203672
Cardiovasc Res. 2023 May 22;119(5):1234-1249
pubmed: 36536484
J Biomed Mater Res A. 2021 Apr;109(4):453-478
pubmed: 32985051
Front Immunol. 2021 Jul 12;12:609615
pubmed: 34322115
Int J Mol Sci. 2021 Nov 07;22(21):
pubmed: 34769465
Acta Biomater. 2021 Oct 1;133:4-16
pubmed: 33775905
J Am Acad Dermatol. 2020 May;82(5):1166-1173
pubmed: 32004648
Medicine (Baltimore). 2021 Jan 22;100(3):e23986
pubmed: 33545988
Int J Cosmet Sci. 2019 Dec;41(6):534-547
pubmed: 31309600
Molecules. 2021 Mar 06;26(5):
pubmed: 33800730
Cells. 2021 Nov 15;10(11):
pubmed: 34831399
J Am Acad Dermatol. 2018 Jan;78(1):148-155
pubmed: 29089180
Mol Ther Oncolytics. 2022 Feb 22;24:799-813
pubmed: 35317518
Clin Med Res. 2018 Jun;16(1-2):16-28
pubmed: 29650525
J Cosmet Dermatol. 2021 Nov;20(11):3415-3421
pubmed: 33626227
J Eur Acad Dermatol Venereol. 2021 Oct;35(10):1963-1975
pubmed: 34077579
Biochem Pharmacol. 2019 Jul;165:152-169
pubmed: 30910693
J Leukoc Biol. 2019 Aug;106(2):283-299
pubmed: 30861205
Clin Cosmet Investig Dermatol. 2021 Nov 09;14:1629-1636
pubmed: 34803388
J Biomater Sci Polym Ed. 2022 Dec;33(18):2406-2432
pubmed: 35848901
Dermatol Ther (Heidelb). 2019 Dec;9(4):775-784
pubmed: 31625112
Int J Mol Sci. 2023 Mar 21;24(6):
pubmed: 36983027
J Am Acad Dermatol. 2020 Feb;82(2):336-343
pubmed: 31150711
Biomaterials. 2021 Jan;268:120552
pubmed: 33307365
Clin Transl Med. 2022 Nov;12(11):e1094
pubmed: 36354147
Inflamm Res. 2023 Jan;72(1):75-88
pubmed: 36329130
Front Immunol. 2021 Nov 23;12:756550
pubmed: 34899707
Bioeng Transl Med. 2021 May 04;6(3):e10215
pubmed: 34589595
Biochem Biophys Res Commun. 2020 Jan 1;521(1):64-71
pubmed: 31627897
Dermatol Ther (Heidelb). 2018 Sep;8(3):379-387
pubmed: 29943217
Bioact Mater. 2021 Apr 30;6(12):4342-4359
pubmed: 33997511
Int Rev Cell Mol Biol. 2019;342:73-93
pubmed: 30635094
Clin Dermatol. 2022 Mar-Apr;40(2):122-127
pubmed: 34819228
Bioorg Med Chem Lett. 2019 Feb 15;29(4):585-590
pubmed: 30600206
Australas J Dermatol. 2020 Nov;61(4):307-311
pubmed: 32761824
Oxid Med Cell Longev. 2019 Dec 13;2019:8135985
pubmed: 31915514
J Hematol Oncol. 2022 Aug 17;15(1):110
pubmed: 35978372
Int J Dermatol. 2020 Jun;59(6):e175-e182
pubmed: 31880327
Front Immunol. 2022 Jul 06;13:888392
pubmed: 35874710
Indian J Ophthalmol. 2023 Apr;71(4):1382-1390
pubmed: 37026270
Exp Dermatol. 2014 Dec;23(12):868-73
pubmed: 25047092
Br J Dermatol. 2017 Feb;176(2):431-438
pubmed: 27718519
Mol Vis. 2021 May 13;27:323-353
pubmed: 34035646
J Invest Dermatol. 2014 Nov;134(11):2728-2736
pubmed: 24844861
Am J Clin Dermatol. 2021 Jul;22(4):457-465
pubmed: 33759078
J Cosmet Dermatol. 2023 Mar;22(3):1001-1010
pubmed: 36374628
Immunol Rev. 2021 Jul;302(1):86-103
pubmed: 34101202
J Eur Acad Dermatol Venereol. 2023 Apr;37(4):796-809
pubmed: 36367676
Expert Rev Clin Immunol. 2022 Dec;18(12):1239-1251
pubmed: 36137266
J Hematol Oncol. 2021 Jun 9;14(1):91
pubmed: 34108022
J Invest Dermatol. 2022 Jul;142(7):1835-1844.e2
pubmed: 34953863
Adv Skin Wound Care. 2022 Oct 1;35(10):535-543
pubmed: 36125453
Front Immunol. 2021 Jul 05;12:674871
pubmed: 34290700
J Am Acad Dermatol. 2021 Apr;84(4):1059-1067
pubmed: 33157177
Animals (Basel). 2020 Jul 24;10(8):
pubmed: 32722259
Adv Drug Deliv Rev. 2022 Sep;188:114422
pubmed: 35810883
J Peripher Nerv Syst. 2023 Jun;28(2):266-268
pubmed: 37119473
J Eur Acad Dermatol Venereol. 2023 Jul;37(7):1415-1425
pubmed: 36971768
Nat Rev Drug Discov. 2020 May;19(5):311-332
pubmed: 32107480
Front Pain Res (Lausanne). 2023 Feb 20;4:1122134
pubmed: 36890854
J Clin Invest. 2021 Mar 1;131(5):
pubmed: 33434186
Surv Ophthalmol. 2018 May - Jun;63(3):340-346
pubmed: 28782548
Biomed Pharmacother. 2023 May;161:114469
pubmed: 37002572
Molecules. 2023 Jan 26;28(3):
pubmed: 36770883
Front Psychiatry. 2021 Jun 16;12:659171
pubmed: 34220573
Front Microbiol. 2020 Aug 27;11:1902
pubmed: 32982998
Front Cell Dev Biol. 2021 Dec 21;9:751785
pubmed: 34993194
Clin Exp Dermatol. 2022 Feb;47(2):259-263
pubmed: 34709676
Biomed Pharmacother. 2019 Mar;111:537-547
pubmed: 30597307
Front Immunol. 2021 May 17;12:669891
pubmed: 34079551
J Am Acad Dermatol. 2002 Apr;46(4):584-7
pubmed: 11907512
Biochem Soc Trans. 2022 Feb 28;50(1):297-308
pubmed: 35191953
PLoS One. 2021 Mar 24;16(3):e0248650
pubmed: 33760854
J Clin Aesthet Dermatol. 2021 Dec;14(12):49-54
pubmed: 35096255
J Biol Regul Homeost Agents. 2020 Jun 1;34(3):767-773
pubmed: 32476380
J Clin Aesthet Dermatol. 2020 Jun;13(6 Suppl):S17-S24
pubmed: 33282106
Cell Immunol. 2021 Oct;368:104422
pubmed: 34399172
J Dtsch Dermatol Ges. 2021 Jan;19(1):7-17
pubmed: 32989925
J Cosmet Dermatol. 2022 Sep;21(9):3759-3767
pubmed: 35765796
Cells. 2021 May 26;10(6):
pubmed: 34073434
J Dermatol. 2022 Dec;49(12):1221-1227
pubmed: 36177741
Nat Rev Clin Oncol. 2020 Mar;17(3):147-167
pubmed: 31848460
Nat Rev Dis Primers. 2022 Jul 21;8(1):50
pubmed: 35864102
J Am Acad Dermatol. 2018 Jan;78(1):156-166
pubmed: 29089181
Diabetes Metab Res Rev. 2022 Mar;38(3):e3502
pubmed: 34614543
Skin Therapy Lett. 2021 Jul;26(4):1-8
pubmed: 34347259

Auteurs

Yi Liu (Y)

Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China.
Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
Medical Cosmetic Center, Chengdu Second People's Hospital, Chengdu, Sichuan, China.

Yin Zhou (Y)

Medical Cosmetic Center, Chengdu Second People's Hospital, Chengdu, Sichuan, China.

Chenyu Chu (C)

Medical Cosmetic Center, Chengdu Second People's Hospital, Chengdu, Sichuan, China.

Xian Jiang (X)

Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China.
Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH